Related Experiment Video
Updated: Jul 10, 2026
08:02
A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
Published on: March 24, 2023
Pharmacotherapy for allergic contact dermatitis.
Sharon E Jacob1, Mari Paz Castanedo-Tardan
1University of Miami, Leonard M. Miller School of Medicine, Department of Dermatology and Cutaneous Surgery, Florida 33124, USA. sjacob@med.miami.edu
Expert Opinion on Pharmacotherapy
|October 25, 2007
Summary
Allergic contact dermatitis (ACD) is common and impacts quality of life. Identifying and avoiding allergens via patch testing is key, but therapies are needed when avoidance isn't feasible.
Area of Science:
- Dermatology
- Immunology
Background:
- Allergic contact dermatitis (ACD) is a prevalent skin condition with significant impact.
- Chronic ACD affects quality of life and incurs economic costs.
- Patch testing is the gold standard for diagnosing ACD.
Purpose of the Study:
- To review therapeutic approaches for allergic contact dermatitis.
- To discuss management strategies when allergen avoidance is not possible.
Main Methods:
- Review of existing literature on ACD treatment.
- Discussion of symptomatic and immunosuppressive therapies.
Main Results:
- Allergen identification and avoidance lead to resolution for many patients.
- Symptomatic and immunosuppressive therapies are options when avoidance fails.
- A structured therapeutic approach is essential for managing ACD.
Conclusions:
- Effective management of ACD requires accurate diagnosis and tailored treatment.
- Therapeutic interventions are crucial for patients unable to avoid allergens.
- This review provides a framework for managing allergic contact dermatitis.
Related Concept Videos
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:30Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
01:30Hypersensitivities
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
02:06Allergic Reactions
Overview